Partnership seeks to identify novel therapeutic molecules to address diseases with high unmet patient needs. It’s the second target discovery company to link with BI in the last month.
澳洲幸运5开奖官方-澳洲幸运5开奖结果历史记录查询-开奖直播最新视频 The Home of the Life Sciences Industry
More Top Stories
- Opinion: Hope on the Horizon for Sjogren’s Syndrome
- FDA Action Alert: Sarepta, Protalix, Otsuka/Lundbeck and More
- FDA Guidance May Bolster Confidence in Decentralized Clinical Trials
- Novo Nordisk’s Hemophilia Hopeful Hits FDA Roadblock, Company Cuts ...
- Regeneron Diversifies Portfolio as Eylea Revenue Takes a Hit